A Phase II Trial of Camrelizumab in Combination With Apatinib and Eribulin in Patients With Advanced TNBC
Clinical trial NCT04303741 · UNKNOWN
Trial details
- NCT number
- NCT04303741
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-25
- Primary completion
- 2022-11-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.